Smithfield Trust’s Atara Biotherapeutics ATRA Stock Holding History

Smithfield Trust’s Portfolio ATRA Stock Details ATRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-29	Closed	-$6K	–	1056
2022 Q2	$6K	Hold	29	–	–	﹤0.01%	913
2022 Q1	$7K	Hold	29	–	–	﹤0.01%	903
2021 Q4	$12K	Hold	29	–	–	﹤0.01%	809
2021 Q3	$13K	Hold	29	–	–	﹤0.01%	781
2021 Q2	$11K	Hold	29	–	–	﹤0.01%	801
2021 Q1	$10K	Buy	29 +7	+32%	+$3.09K	﹤0.01%	830
2020 Q4	$11K	Buy	22 +8	+57%	+$3.69K	﹤0.01%	788
2020 Q3	$5K	Hold	14	–	–	﹤0.01%	913
2020 Q2	$5K	Buy	14 +7	+100%	+$1.77K	﹤0.01%	843
2020 Q1	$2K	Hold	7	–	–	﹤0.01%	872
2019 Q4	$3K	Hold	7	–	–	﹤0.01%	854
2019 Q3	$3K	Hold	7	–	–	﹤0.01%	891
2019 Q2	$4K	Hold	7	–	–	﹤0.01%	827
2019 Q1	$7K	Hold	7	–	–	﹤0.01%	709
2018 Q4	$6K	Buy	+7	New	+$6.5K	﹤0.01%	716

Other funds holding ATRA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return